Bexarotene clinical trials
Also written Targretin and LGD1069.
How each study uses Bexarotene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Bexarotene studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Dec 1999 · TARGRETIN · NDA 021055 (FDA, Drugs@FDA)
- European Union
- 29 Mar 2001 · Targretin · EMEA/H/C/000326 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
30 studies that test it; most in 2001 (5)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2001 | 5 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 3 |
| 2010 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 26
Memorial Sloan Kettering Cancer Center (3) · M.D. Anderson Cancer Center (2) · Abramson Cancer Center at Penn Medicine (2) · Ligand Pharmaceuticals (2) · Eisai Inc. (2) · Beersheva Mental Health Center (2) · Stanford University (1) · National Cancer Centre, Singapore (1)
Often tested with
Tested in the same studies.
Erlotinib (2) · Gefitinib (1) · Pralatrexate (1) · Rosiglitazone (1) · Gemcitabine (1) · Decitabine (1) · Carboplatin (1) · Paclitaxel (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test Bexarotene.
- Mar 2027A Study of Bexarotene Combined With Radiotherapy in People With Mycosis FungoidesPhase 1 · Memorial Sloan Kettering Cancer Center
Studies
Open first, then newest update. How each study uses Bexarotene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 33
- A Study of Bexarotene Combined With Radiotherapy in People With Mycosis FungoidesRecruitingPhase 1Memorial Sloan Kettering Cancer CenterNCT05296304Written as Bexarotene
- A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung CancerCompletedPhase 1/2Stanford UniversityNCT00238628Written as Bexarotene
- The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBCCompletedPhase 1National Cancer Centre, SingaporeNCT04664829Written as Bexarotene
- Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast CancerCompletedPhase 1National Cancer Institute (NCI)NCT03323658Written as Bexarotene
- Phase II Study of Bexarotene in Patients With Acute Myeloid LeukemiaTerminatedPhase 2Abramson Cancer Center at Penn MedicineNCT00615784Written as Bexarotene
- BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedPhase 2M.D. Anderson Cancer CenterNCT00411632Written as Bexarotene
- Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaCompletedPhase 1Acrotech Biopharma Inc.NCT01134341Written as Bexarotene Capsules
- Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)CompletedPhase 4Bausch Health Americas, Inc.NCT01007448Written as Bexarotene
- A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung CancerTerminatedPhase 1/2Dartmouth-Hitchcock Medical CenterNCT00153842Written as Bexarotene (targretin)
- Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung CancerCompletedPhase 2Konstantin DragnevNCT00125359Written as erlotinib and bexarotene
- Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT00425477Written as bexarotene
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell LymphomaCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00255801Written as Targretin® (bexarotene)
- Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis FungoidesTerminatedPhase 3European Organisation for Research and Treatment of Cancer - EORTCNCT00056056Written as bexarotene
- Study of Bexarotene in Patients With Acute Myeloid LeukemiaCompletedPhase 1Abramson Cancer Center at Penn MedicineNCT00316030Written as Bexarotene
- Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCLCompletedPhase 2Vanderbilt UniversityNCT00178841Written as Rosiglitazone and Bexarotene
- Bexarotene Amyloid Treatment for Alzheimer's DiseaseCompletedPhase 2The Cleveland ClinicNCT01782742Written as Bexarotene
- A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy SubjectsCompletedPhase 1ReXceptor, Inc.NCT02061878Written as Bexarotene
- Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin LymphomaCompletedPhase 2University College, LondonNCT00660231Written as bexarotene
- Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)CompletedPhase 1Washington University School of MedicineNCT01001143Written as Bexarotene
- A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) ExpressionCompletedEarly Phase 1University of Colorado, DenverNCT00718770Written as Bexarotene
See all 33 studies that test Bexarotene →
Given beside what is tested · 5 — Bexarotene is usual care or a partner of the new treatment
- Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.WithdrawnNot applicableCase Comprehensive Cancer CenterNCT05106192Written as Bexarotene 1% Top Gel
- Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive TractCompletedPhase 1Dartmouth-Hitchcock Medical CenterNCT01116622Written as Bexarotene (Targretin®)
- Phase I Study of CS-7017 and BexaroteneTerminatedPhase 1Georgetown UniversityNCT01504490Written as CS-7017 and Bexarotene
- An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)TerminatedPhase 1Merck Sharp & Dohme LLCNCT00127101Written as Comparator: bexarotene
- Bexarotene Augmentation of Antipsychotic Treatment for Chronic SchizophreniaCompletedPhase 3Beersheva Mental Health CenterNCT00535574Written as Bexarotene (Targretin LGD1069)
As the comparator · 1 — what is tested is compared with Bexarotene
Codes
What other systems call Bexarotene · ClinicalTrials.gg INT006780
- MeSH (NLM) D000077610BexaroteneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) A61RXM4375BEXAROTENEConfirmed FDA, NLM, Wikidata
- RxNorm 233272Confirmed FDA, Wikidata
- Wikidata Q418192bexaroteneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1635BexaroteneOne source FDA
- DrugBank DB00307One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077610 | Bexarotene | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | A61RXM4375 | BEXAROTENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 233272 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418192 | bexarotene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1635 | Bexarotene | One source FDA |
| DrugBank | DB00307 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.